Does IBRUTINIB Cause Hepatic lesion? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Hepatic lesion have been filed in association with IBRUTINIB (Imbruvica). This represents 0.0% of all adverse event reports for IBRUTINIB.
26
Reports of Hepatic lesion with IBRUTINIB
0.0%
of all IBRUTINIB reports
10
Deaths
12
Hospitalizations
How Dangerous Is Hepatic lesion From IBRUTINIB?
Of the 26 reports, 10 (38.5%) resulted in death, 12 (46.2%) required hospitalization, and 1 (3.8%) were considered life-threatening.
Is Hepatic lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IBRUTINIB. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does IBRUTINIB Cause?
Death (8,007)
Off label use (5,446)
Fatigue (4,479)
Diarrhoea (3,903)
Atrial fibrillation (3,671)
Pneumonia (3,015)
Incorrect dose administered (2,752)
Contusion (2,712)
Fall (2,375)
Asthenia (2,200)
What Other Drugs Cause Hepatic lesion?
OCTREOTIDE (296)
EVEROLIMUS (171)
RIBOCICLIB (144)
LETROZOLE (139)
CAPECITABINE (124)
ADALIMUMAB (123)
METHOTREXATE (108)
FULVESTRANT (107)
PALBOCICLIB (104)
CYCLOPHOSPHAMIDE (101)
Which IBRUTINIB Alternatives Have Lower Hepatic lesion Risk?
IBRUTINIB vs IBUPROFEN
IBRUTINIB vs IBUPROFEN LYSINE
IBRUTINIB vs IBUPROFEN UNKNOWN PRODUCT
IBRUTINIB vs IBUPROFEN\IBUPROFEN
IBRUTINIB vs IBUPROFEN\PHENYLEPHRINE